Method and composition for cancer diagnosis and treatment

Details for Australian Patent Application No. 2008298345 (hide)

Owner Suzhou Ascentgene Co., Ltd.

Inventors Ge, Hui

Agent Shelston IP

Pub. Number AU-A-2008298345

PCT Pub. Number WO2009/033411

Priority 60/970,686 07.09.07 US

Filing date 5 September 2008

Wipo publication date 19 March 2009

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

1 April 2010 PCT application entered the National Phase

  PCT publication WO2009/033411 Priority application(s): WO2009/033411

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008298387-Walk-in seat

2008298307-Alkylsulfone derivative